Property | Value |
?:abstract
|
-
Retrospective multicentre cohort study of all endoscopic procedures performed between 4/27 and 6/15-2020. A screening questionnaire(SQ) was run to the patients 3 days prior to the procedure and 14 days after. Also, a serologic SARS-CoV-2 test was performed 48 hours before. RESULTS: 211 consecutive patients with endoscopic procedures were included. No patients with a positive initial or 14 days later SQ. Only 4 patients had antibody positives, 1.9%(IC 95%:0.07-4.8%). CONCLUSION: The pre-endoscopy seroprevalence of SARS-CoV-2 is low in this cohort. The Pre-Procedural SARS-CoV-2 Antibody Testing does not add any benefits over clinical SQ in order to identify active COVID-19 patients.
|
is
?:annotates
of
|
|
?:creator
|
|
?:doi
|
|
?:doi
|
-
10.17235/reed.2020.7434/2020
|
?:journal
|
-
Revista_espanola_de_enfermedades_digestivas_:_organo_oficial_de_la_Sociedad_Espanola_de_Patologia_Digestiva
|
?:license
|
|
?:pmid
|
|
?:pmid
|
|
?:publication_isRelatedTo_Disease
|
|
?:source
|
|
?:title
|
-
Pre-Procedural Antibody Testing for SARS-CoV-2 in routine endoscopic practice.
|
?:type
|
|
?:year
|
|